Revenue at Rs. 2,182 Crore up 5% YoY; EBITDA at Rs 444 Crores down 1% YoY PAT at Rs 185…
JUBILANT REPORTS RECORD PERFORMANCE IN FY'19 Revenue up 21% YoY to Rs. 9,111 Crore; EBITDA up 14% YoY to Rs 1,775…
New Delhi, February 02, 2019: JUBILANT REPORTSRECORD PERFORMANCE IN Q3’FY19 Revenue up 15% YoY to Rs. 2,377 Crore; EBITDA up…
New Delhi, January 19, 2018: Jubilant Life Sciences Limited is an integrated global pharmaceutical and life sciences company engaged in…